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Abstract
: Children from low- and middle-income countries have poorBackground
asthma control, mainly because of poor management. The extent of this
problem in Uganda is not well known, but such information would be useful
to guide policy and practice. We therefore conducted a cross-sectional
study among schoolchildren with asthma in urban Uganda, to assess the
level of asthma control and management.
: Schoolchildren aged 5-17 years were enrolled, asthma wasMethods
diagnosed by the study medical team. Asthma control was assessed using
the Asthma Control Test and the childhood Asthma Control Test. Data on
previous asthma management was obtained using interviewer-led
questionnaires. Data were analysed using multiple linear and multiple
logistic regression.
: We enrolled 561 children with asthma, of whom only 56% hadResults
ever had an asthma diagnosis. We categorised asthma as well-controlled
(55.5%), partly-controlled (29.5%) and poorly-controlled (15.0%). Poor
asthma control was associated with increasing age (adjusted regression
coefficient [95% confidence interval], p-value: -1.07 [-1.20, -0.94],
p<0.0001), concurrent allergic rhinitis (-1.33 [-2.28, -0.38], p=0.006), and
city residence in early life (-1.99 [-3.69, -0.29], p=0.06). Regular use of
inhaled asthma medication in the last 12 months was very low; 18.1% for
salbutamol and 6.7% for inhaled corticosteroids. The main barriers to
inhaled asthma medication use were lack of prescription (47.6%) and
inaccurate diagnosis (38.8%). Increased inhaler use was associated with
tertiary education of the fathers (adjusted odds ratio [95% confidence
interval], p-value: 5.19 [2.39-11.28], p<0.0001), city residence in early life
(4.66 [1.79-12.43], 0.002) and an asthma diagnosis prior to enrolment
(11.39 [6.35-20.43], p<0.0001).
: This study confirms that children with asthma in UgandaConclusions
generally have inadequate asthma control, which is attributable to poor
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generally have inadequate asthma control, which is attributable to poor
asthma management. This could be improved through re-training of
medical workers and patient education, and by increasing availability and
affordability of essential asthma medications.
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Background
Poor asthma control among children in low- and middle-
income countries (LMICs) is believed to be relatively com-
mon, and mainly because of poor asthma management. Studies 
have shown increased asthma severity among children in LMICs 
compared to children in high income countries (HICs)1. The 
health systems in most LMICs are not well adapted to the 
management of chronic conditions2. In several LMICs, essen-
tial asthma medications, such as inhaled bronchodilators 
(salbutamol) and inhaled corticosteroids, are not on the coun-
try’s essential drugs lists3 and are not easily available4. This 
leads to poor asthma control, higher rates of asthma attacks 
and higher mortality5.
The level of asthma control and management among 
children from the general population has not been investigated 
in Uganda, and there have been few investigations in other low 
income countries. This information is important in informing 
policy on the extent of the problem, and in identifying areas 
where improvements could be made cost-effectively. We there-
fore conducted a cross-sectional study among schoolchil-
dren in urban Uganda with asthma, to assess their levels of 
asthma control and previous management.
Methods
Study design
This cross-sectional study included all schoolchildren with 
asthma who participated in a large case-control study whose 
aim was to investigate the risk factors for asthma6. We 
report using the STROBE guidelines7.
Study population, recruitment and consent
We recruited schoolchildren, 5–17 years, from primary and 
secondary schools in an urban area of Wakiso District, in cen-
tral Uganda. At each school, all children were pre-screened for 
breathing problems by the study nurses; this involved requesting 
all children with any current breathing problems to register 
with the study team or the class teacher. Children with any 
self-reported breathing problems were provided with cards 
inviting their parents or guardians for a parents’ meeting. 
During the meeting, the study team explained what the study 
was about, talked about asthma in general and responded to any 
questions or concerns that the parents raised. Parents or guard-
ians interested in their child participating in the study provided 
written informed consent for participation in the study and 
publication of anonymised study findings. The consent proc-
ess was conducted in either English or Luganda (the main 
local language). Children eight years or older provided 
written informed assent. Study enrolment was between May 2015 
and July 2017.
Ethical approval
The study was approved by the Uganda Virus Research Insti-
tute Research and Ethics Committee (reference number: 
GC/127/14/09/481), and the Uganda National Council for Science 
and Technology (reference number: HS 1707).
Asthma diagnosis
All study procedures were conducted at the school premises, 
to minimise interruption of the pupils’ studies. We screened 
for asthma with the International Study of Asthma and Aller-
gies in Childhood (ISAAC) questionnaire8. Children with 
wheezing in the last 12 months were further assessed by the 
study medical or clinical officers, including a detailed medical 
and treatment history reported by parents or adolescents and 
clinical assessments including spirometry. Asthma diagno-
sis was mostly clinical, as a history of recurrent symptoms of 
wheezing, chest tightness, shortness of breath and cough (that 
is mostly dry, worse at night and in the morning). In addition, 
we assessed for forced expiratory volume in the first second 
(FEV
1
) and considered values <80% of the expected values 
for age, sex, height and race abnormal. However, this contrib-
uted to, but was not a requirement for, the asthma diagnosis. 
We enquired, from the parents or the adolescents, about 
medical history of a prior physician asthma diagnosis and good 
response to asthma medication. For children whose asthma 
diagnosis was not straightforward, two clinicians reviewed 
that participant and if they disagreed, that participant was 
excluded from the study. Children who did not report asthma 
symptoms in the last 12 months were also excluded from 
this study.
We collected data on asthma symptoms in the last four 
weeks using the childhood Asthma Control Test (c-ACT)9 for 
children less than 12 years, and the Asthma Control Test (ACT) 
for children 13 years and older10. We enquired about asthma 
medications that the children had ever used in the past, as 
well as medications that they had used regularly because of 
asthma symptoms in the last 12 months. Questionnaires11 were 
interviewer-led and were answered by either the adolescents 
or by the parents/guardians for the younger children.
The clinical assessments included spirometry using a handheld 
device (Micro 1 Diagnostic Spirometer, CareFusion, Chatham 
Marine, United Kingdom); skin prick tests (SPT) with seven 
allergen extracts (Dermatophagoides mix [D. farinae and 
D. pteronyssminus], Blomia tropicalis, Blattella germanica, 
peanut, cat, pollen mix [weeds], and mould mix [Aspergillus 
mix], with negative saline and positive histamine controls 
[ALK Abello, Hoersholm, Denmark]), using standard proce-
dures described previously12. This involved pricking through 
droplets of the allergens on the volar aspect of the participant’s 
arm with a skin lancet; the size of the wheal was measured 
after 15 minutes. Fractional exhaled nitric oxide (FENO) was 
measured using a handheld device (NoBreath® from Bedfonf 
Scientific, Maidstone, United Kingdom).
Data management and statistical methods
Data were collected using pre-coded questionnaires11 and dou-
ble entered into OpenClinica open source software version 
3.1.4 (OpenClinica LLC and collaborators, Waltham, MA, 
USA), and analysed in STATA, version 15 (StataCorp, Texas, 
USA).
For analyses where the outcome was asthma control scores as 
a continuous variable, the independent t-test or one-way 
ANOVA were used for univariate analysis, and multiple lin-
ear regression was used to control for confounders. For 
binary outcomes, we used standard chi square tests and mul-
tiple logistic regression. We built the final multiple regression 
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models by adding one potential confounder at a time and 
examined the change in the main effect estimate; factors that 
were closely related (such as father’s and mother’s 
education level, or area of residence at birth and in the first 
five years) were not included in the same model to avoid 
multicollinearity13. We did not impute for missing data.
Results
Characteristics of study participants
We enrolled 562 children with asthma from 55 schools, but one 
child was excluded from the current analysis because of incom-
plete data. Detailed participant flow diagram is published6. At 
enrolment, only four children had wheezing symptoms; and 
of 477 (85%) children who successfully underwent spirom-
etry, only three had forced expiratory volume in the first second 
(FEV
1
) values less than 80% of predicted values14. The mean 
age was 11.4 years (range 5–17 years), 52.8% were girls 
and 47.3% and 37.9% had fathers and mothers with tertiary 
education, respectively (Table 1). Based on the ISAAC ques-
tionnaire, 28.7% children reported four or more wheez-
ing attacks in the last 12 months; 71.9% reported that their 
chest sounded wheezy during or after exercise in the last 
12 months; 74.0% reported a dry cough at night in the last 
12 months that was not associated with a common cold or 
chest infection; however, only 55.9% had ever had an asthma 
diagnosis (Table 1).
Factors associated with asthma control
Total scores from the ACT and c-ACT were generated for 
each child, using the standard cut-off points of >19 for well-
controlled, 15–19 for partly controlled, and <15 for poorly 
controlled asthma. Asthma control categories were 55.5% 
well-controlled, 29.5% partly controlled and 15.0% poorly 
controlled (Table 1).
We assessed factors associated with asthma control, based on 
ACT and c-ACT test scores (low scores indicate poorer asthma 
control). We found that older children were more likely to 
have lower asthma control scores (adjusted coefficient [95% 
confidence interval], p-value: -1.07 [-1.20, -0.94], p<0.0001); 
children who reported regular vigorous physical activity three 
or more times a week (WHO recommendation15) had higher 
scores (0.84 [0.01, 1.67], p=0.05); children with concurrent 
allergic rhinitis had lower scores (-1.33 [-2.28, -0.38], p=0.006); 
children who reported receiving antimalarial medication twice 
or more in the last 12 months had lower scores (-1.38 [-2.31, 
-0.45], p=0.007); and children who spent most of their first five 
years in the city had lower scores (-1.99 [-3.69, -0.29], p=0.06) 
(Table 2). However, SPT and FENO were not significantly 
associated with asthma control.
Reported medications previously used for asthma
Only 26.8% (148/553) children reported having ever used 
inhaled asthma medications, and 29.7% (164/553) reported 
having ever used herbal remedies for asthma management. 
Participants reported that the medications they used regu-
larly (for asthma symptoms) in the last 12 months were steroid 
tablets (particularly prednisolone, 27.0%), salbutamol inhaler 
(18.1%), salbutamol tablets (17.4%), inhaled corticosteroids 
(6.7%), antihistamines (particularly cetirizine, 6.2%), amino-
phylline tablets or injections (5%), unspecified cough remedies 
(4.6%), antibiotics (2.8%), other unspecified tablets (2.6%), 
herbal remedies (2.5%), and nebulised salbutamol (1%).
We looked at the correlation between asthma control in the 
last four weeks and type of asthma medication used in the 
last 12 months. This was to assess the proportion of children 
currently with poor asthma control who had received the 
correct asthma treatment at any point in the last 12 months. 
We found that among 83 children currently with poorly 
controlled asthma, only 19 (20.9%) and six (7.2%) had used 
Table 1. Characteristics of the Ugandan schoolchildren 
with asthma (N=561).
Characteristic n %
Age (years) mean, range (m=1) 11.4 5 - 17
Sex
Boys 265 47.2
Girls 296 52.8
Father’s highest education level attained (m=5)
None/Primary 99 17.8
Secondary 194 34.9
Tertiary 263 47.3
Mother’s highest education level attained (m=7)
None/Primary 159 28.7
Secondary 185 33.4
Tertiary 210 37.9
Number of wheezing attacks in the last 12 months‡ (m=4)
One 150 26.9
2–3 247 44.4
4 or more 160 28.7
Ever had asthma diagnosis (m=8)‡
Yes 309 55.9
Chest sounded wheezy during or after exercise (m=9)‡
Yes 397 71.9
Had dry cough at night not associated with a cold, ‘flu’ 
or chest infection (m=8)‡
Yes 409 74.0
Asthma control in the last four weeks, based on ACT 
and cACT scores (m=8)
Well controlled (scores >19) 307 55.5
Partly controlled (scores15–19) 163 29.5
Poorly controlled (scores <15) 83 15.0
N, number; m, missing; ‡Based on the International Study of Asthma 
and Allergies in Childhood (ISAAC) questionnaire; ACT, Asthma 
Control Test; cACT, childhood Asthma Control Test.
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inhaled salbutamol and inhaled corticosteroids, respectively, 
in the last 12 months (Table 3). Instead, a larger propor-
tion had regularly used salbutamol tablets (26.5%) and steroid 
tablets (28.9%). We observed that of the 307 children with well- 
controlled asthma, 153 (49.8%) reported not using salbuta-
mol or steroids in any formulation (Table 3), suggesting that 
perhaps they had mild asthma.
Reported previous asthma assessments
We also enquired about previous asthma assessments and 
follow-up, and found that only 45 (8.2%) children had ever 
had a lung function test; only two (0.4%) had ever used a peak 
flow meter to monitor their asthma at home; 13.2% reported 
visiting a health facility to monitor their asthma; and only three 
(0.5%) had a personal written asthma action plan.
Table 2. Factors associated with asthma control test scores among Ugandan 
schoolchildren.
Participants’ characteristics
Asthma control test scores# N=553
Univariate analysis Multivariate analysis‡
Mean (SD) p-value Adjusted mean 
difference (95% CI)
p-value
Age [m=1]
5–12 years (n=338) 27.32 (3.80) ref
13–17 years (214) 18.37 (4.60) <0.0001 -1.07 (-1.20, -0.94) <0.0001
Sex
Male (261) 25.18 (5.46) ref
Female (292) 22.68 (6.23) <0.0001 -0.54 (-1.34, 0.26) 0.18
Regular physical exercise as recommended by WHO
No (251) 21.91 (6.08) ref
Yes (302) 25.49 (5.44) <0.0001 0.84 (0.01, 1.67) 0.05
Concurrent allergic rhinitis [m=1]
No (434) 24.40 (5.97) ref
Yes (118) 21.88 (5.77) 0.0001 -1.33 (-2.28, -0.38) 0.006
Received antimalarial treatment in the last 12 months [m=1]
None (208) 24.45 (5.89) ref
Once (169) 24.56 (5.76) -0.15 (-1.08, 0.78)
Twice or more (175) 22.48 (6.19) 0.001 -1.38 (-2.31, -0.45) 0.007
Area of residence in first five years of life
Rural (71) 23.62 (5.18) ref
Town (433) 24.18 (6.09) -0.60 (-1.77, 0.57)
City (49) 21.37 (5.86) 0.007 -1.99 (-3.69, -0.29) 0.06
Skin prick test responses [m=9]
Negative (<3mm) (244) 24.00 ref
Positive (≥3mm) (300) 23.75 0.63 -0.51 (-1.31, 0.29) 0.21
Fractional exhaled nitric oxide levels [m=13]
Normal (<35ppb) (335) 23.91 ref
Elevated(≥35ppb) (195) 23.62 0.59 0.42 (-0.39, 1.24) 0.31
N, number; SD, standard deviation; CI, confidence interval; ref, reference; m, missing; WHO, World 
Health Organisation; ppb, parts per billion.
#Asthma control test scores are based on Asthma Control Test (ACT) and childhood Asthma Control 
Test (cACT); scores ranged from 8–34, low scores indicating poor asthma control and high scores 
indicating well controlled asthma.
‡Final linear regression model adjusted for age, sex, exercise as recommended by WHO, concomitant 
allergic rhinitis, antimalarial treatment, area of residence in early life and father’s education level; 
(model constant =37.30, R2=0.44, F-ratio [10, 537] =41.69, p<0.0001, N=548).
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Factors associated with having ever used inhaled asthma 
medication
We assessed factors associated with having ever used inhaled 
asthma medication, and found these were mother’s and father’s 
tertiary education (adjusted odds ratio [95% confidence inter-
val]: 2.91 [1.61-5.25] and 5.19 [2.39-11.28], respectively); 
the child’s area of residence in early life (city residence at 
birth, 4.66 [1.79-12.43] or in the first five years, 2.99 [1.11-8.05]); 
and having ever had an asthma diagnosis (11.39 [6.35-20.43]) 
(Table 4).
Barriers to inhaled asthma medication use
We investigated why 405 of 553 (73%) children enrolled in 
this study had never used inhaled asthma medications, which 
are the mainstay of treatment including mild asthma16. The 
reasons included that inhaled asthma medication had never 
been prescribed for them (47.6%, including children with a 
previous asthma diagnosis); no asthma diagnosis (38.8%); 
high cost of inhalers (4.5%); fear of side-effects of inhalers 
(4.5%); and alternative treatment with herbal or cough rem-
edies (2.2%), or with salbutamol or steroid tablets (1.4%). Some 
children (1%) reported wrapping up in warm clothes or resting, 
without any medication.
Reported asthma triggers, and treatment offered
The children reported the following, non-mutually exclusive, 
triggers for asthma: cold air (89.1%), chest infections (84.0%), 
physical exercise (78.0%), dust (66.8%), fumes or air pollution 
(61.9%), emotional distress or excitement (21.6%), pollen 
or pets (6.5%).
All children were offered one course of asthma treatment 
according to the Global Initiative for Asthma (GINA) 2015 
treatment guidelines17. This was determined by the study clini-
cians, using participants’ detailed asthma symptoms reported 
on the Asthma Control Test (ACT) or childhood Asthma 
Control Test (cACT). According to the GINA 2015 guidelines, 
279 (50.4%) children received step I [salbutamol inhaler as 
needed], 209 (37.8%) children step II [salbutamol inhaler as 
needed and low dose inhaled corticosteroids], 52 (9.4%) chil-
dren step III [salbutamol inhaler as needed, and low dose inhaled 
corticosteroids and long acting beta
2
-agonist], and 13 (2.4%) 
children step IV [salbutamol inhaler as needed, and medium 
dose inhaled corticosteroids and long acting beta
2
-agonist]. 
None received step V treatment. Participants were then referred 
to one of the two asthma clinics in the study area for further 
management, according to their preference.
Discussion
We found that asthma control among Ugandan schoolchildren 
was poor, and this was mainly related to inadequate manage-
ment. About half the children had either partly or poorly con-
trolled asthma in the previous four weeks, 44% had asthma 
that had never been diagnosed, and only 7% had used the 
Table 3. Asthma control in last four weeks and regularly used asthma medications in the last  
12 months (N=553).
Regular 
asthma 
medication 
in the last 
12 months
Asthma control in the last four weeks (ACT and cACT scores)
Well controlled, n (%) 
(scores >19) N=307
Partly controlled, n (%) 
(scores 15–19) N=163
Poorly controlled, n (%) 
(scores <15) N=83
p-value
Salbutamol inhaler
Yes (n=100) 51 (16.6) 30 (18.4) 19 (20.9) 0.42
Inhaled corticosteroids
Yes (37) 22 (7.2) 9 (5.5) 6 (7.2) 0.78
Salbutamol tablets
Yes (96) 45 (14.7) 29 (17.8) 22 (26.5) 0.04
Steroid tablets (mostly prednisolone)
Yes (149) 86 (28.1) 39 (23.9) 24 (28.9) 0.57
Neither salbutamol nor steroids 
Yes (225) 153 (49.8) 50 (30.7) 22 (26.8) <0.0001
Other medications§
Yes (121) 68 (22.2) 32 (19.6) 21 (25.3) 0.59
ACT= Asthma Control Test; cACT=childhood Asthma Control Test; N=number; 2nd-4th columns show numbers 
(percentages).
§Other medications mainly included aminophylline (tablets or injection), antihistamines, antibiotics, various cough 
and herbal remedies. Only three reported nebulised salbutamol. None reported leukotriene modifiers (such as 
montelukast) or antimalarials.
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recommended inhaled corticosteroids in the last 12 months. 
These findings confirm that children with asthma in Uganda 
have poor asthma management, which stems from systemic 
failures of the health system.
The level of asthma control we observed was similar to that 
reported in a study from Cameroon18. We found that poor 
asthma control was associated with three factors: increas-
ing age, concurrent allergic rhinitis and city residence in 
early life. The association between concurrent allergic rhini-
tis and poor asthma control has been reported elsewhere19. The 
association between city residence in early life and poor asthma 
control was particularly interesting. Our earlier work found 
that asthma risk among schoolchildren who resided in the city 
in their early years was three times higher than their class-
mates who resided in rural areas in early life6. This suggests 
that city residence in early life is associated with both increased 
asthma risk and asthma severity.
Children with poor asthma control were less likely to engage 
in regular physical exercise. For some children, this was their 
way of controlling asthma symptoms. Other studies have 
observed that children with asthma symptoms avoid activities or 
exercise20,21. What was intriguing was the finding that children 
with poor asthma control were more likely to have received 
several doses of antimalarial treatment in the last year, yet 
Table 4. Factors associated with having ever used inhaled asthma 
medication.
Characteristic Ever used inhaled 
treatment? (N=553)
Adj. OR (95% CI)# p-value
Yes n (%) No n (%)
Mother’s education (m=6)
None/primary (n=154) 24 (15.6) 130 (84.4) 1
Secondary (183) 43 (23.5) 140 (76.5) 1.26 (0.68-2.35)
Tertiary (210) 81 (38.6) 129 (61.4) 2.91 (1.61-5.25) 0.0002
P-value for trend p<0.0001
Father’s education (m=4)
None/primary (97) 10 (10.3) 87 (89.7) 1
Secondary (189) 44 (23.3) 145 (76.7) 2.24 (1.00-5.02)
Tertiary (263) 94 (35.7) 169 (64.3) 5.19 (2.39-11.28) <0.0001
P-value for trend p<0.0001
Area of residence at the time of the child’s birth
Rural (74) 9 (12.2) 65 (87.8) 1
Town (411) 106 (25.8) 305 (74.2) 1.93 (0.86-4.35)
City (68) 33 (48.5) 35 (51.5) 4.66 (1.79-12.43) 0.002
P-value for trend P=0.001
Area of residence where child spent most of 0–5 years
Rural (71) 10 (14.1) 61 (85.9) 1
Town (433) 114 (26.3) 319 (73.7) 1.60 (0.73-3.50)
City (49) 24 (49.0) 25 (51.0) 2.99 (1.11-8.05) 0.08
P-value for trend p=0.03
Ever had asthma diagnosis (m=7)
No (241) 17 (7.0) 224 (93.0) 1
Yes (305) 131 (42.9) 174 (57.1) 11.39 (6.35-20.43) <0.0001
N, number; Adj.OR, adjusted odds ratio; CI, confidence interval; m, missing;
#Adjusted for child’s age and sex, father’s education, area residence at birth, asthma 
diagnosis ever, and asthma control.
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antimalarials were not among medications that children reported 
using to control asthma symptoms. This is the first report 
of this kind. We did not ascertain whether these antima-
larials were prescribed by medical workers or were self- 
administered. In Uganda, the antimalarials currently in use 
are artemisinin and its derivatives artesunate and artemether, 
which are either freely available from health service providers 
or easily available as over-the-counter medications (a positive 
laboratory test is not a requirement). It is important to inves-
tigate why poor asthma control was associated with increased 
use of antimalarials.
Asthma management in this urban area was very poor. Although 
inhaled medications (salbutamol and inhaled corticosteroids) 
are the main stay of asthma treatment16, less than one-third of 
the children with asthma in this setting had ever been treated 
with any form of the recommended inhaled medication, 
and only 20% utilised inhaled salbutamol and 7% inhaled cor-
ticosteroids in the last 12 months. These percentages were 
no better for children with poor asthma control in the last 
four weeks. This suggests that the poor asthma control could 
be attributed to lack of correct asthma treatment. Instead, 
children with asthma were using inferior medications such 
as salbutamol tablets, which are known to cause numerous 
side-effects, and medications that have no role in asthma treat-
ment, such as antihistamines, cough and herbal remedies. 
This was particularly disappointing because salbutamol and 
beclomethasone (an inhaled corticosteroid) inhalers are on 
the country’s Essential Medicines and Health Supplies list 
(EMHSLU) and in the National Treatment Guidelines.
Medical workers played an important role in the inadequate 
asthma management that we observed, from diagnosis and pre-
scription to follow-up. Their inadequate prescription of inhaled 
asthma medications may have been related to the limited 
availability and affordability of inhaled asthma medications, as 
previously reported22. However, their lack of accurate pre-
scriptions could also have been related to their general lack of 
knowledge on current asthma management guidelines, which 
emphasise inhaled rather than oral formulations of salbuta-
mol and steroids. Accurate asthma diagnoses were not always 
made. We noted that children with a prior asthma diagnosis had 
increased chances of having received inhaled asthma treatment, 
and that parents with tertiary education and those in the city 
were able to seek appropriate treatment for their children’s 
asthma. Therefore, there is an urgent need to re-train medi-
cal workers in asthma management in this setting, and to 
update the country’s National Treatment Guidelines to reflect 
the internationally recognised GINA guidelines, in which 
salbutamol tablets have no role in asthma treatment.
We recognise three main limitations of this study. First, 
because of the cross-sectional design, there was no follow-
up of participants and therefore, we were not able to assess 
asthma severity. Asthma severity depends on the level of treat-
ment required to control symptoms and exacerbations. Secondly, 
this study was not designed to collect data from health workers; 
therefore, we did not establish why health workers did not 
routinely prescribe inhaled asthma medications. Thirdly, we 
included only children with a history of wheezing and other 
asthma symptoms in the last 12 months, which may have 
excluded children with well-controlled asthma. This poten-
tial selection bias is likely to have introduced only minor 
imprecision to our findings.
The strength of this study was the large number of children with 
asthma recruited from the general population, thereby increas-
ing the generalisability of the study findings. Our results sug-
gest that the poor asthma management observed could be 
improved by: re-training health workers in asthma diagno-
sis and management; increasing patient and public education 
about asthma; increasing the availability and affordability of 
inhaled asthma medication; and updating the essential drugs 
list and national treatment guidelines to include the basic 
inhaled asthma medications recommended by the GINA treat-
ment guidelines. Given the increasing prevalence of asthma 
among children in urban areas in LMICs, policy makers must 
prioritise asthma management at all levels of the health 
system. Medical training in the country needs to adapt to the 
epidemiological transition towards non-communicable diseases.
Conclusion
This study confirms that several children in Uganda have 
inadequately controlled asthma, mostly because of lack of 
accurate diagnosis, treatment and follow-up.
Data availability
Underlying data
LSHTM Data Compass: SONA project - Asthma management 
data. https://doi.org/10.17037/DATA.0000135814.
This project contains the following underlying data:
-    SONA_management_data.csv (This dataset includes 
all the variables that were used in this analysis. This 
includes participant demographics, previous asthma 
treatment and management history, asthma control and 
assessments at enrolment)
-    Codebook.html (codebook for asthma management 
dataset)
Extended data
LSHTM Data Compass: SONA project – Asthma management 
questionnaire: https://doi.org/10.17037/DATA.0000140511.
This project contains the following extended data:
-    Asthma management questions (questionnaire in PDF 
and Microsoft Word format)
Data are available under the terms of the Creative Commons 
Attribution 3.0 International license (CC-BY 3.0).
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lack of prescription from their physician, also when asthma diagnosis was present. This suggest
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Conclusion: Data from the current study do indicate that the inadequate asthma control among a high
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children were eligible at all schools? 562 children out of how many? n/N
Results: 
Interesting and clearly presented.
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management.
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This is an interesting cross-sectional study whose objective was to assess the level of asthma control and
management among school children aged 5 to 17 years with asthma in an urban area of Wakiso District in
Uganda.
Comments:
It is not quite clear in the methods what the definition used for designating a school child as
asthmatic was. Was asthma defined using the ISAAC definition or it was “mostly clinical as a
history of recurrent symptoms of wheezing, chest tightness, shortness of breath and cough that is
mostly dry, worse at night and in the morning”? This should be made clear.
 
By prescreening and screening for asthma only among children with “any current breathing
problems”, it can be assumed that there was some selection bias as children with well controlled
asthma might not have indicated that they had any current breathing problem. In this case the
study might have recruited mostly children whose asthma was not well controlled. This could
therefore lead to an over-estimation of poorly managed asthma in this population.
 
It is important to indicate how many children were prescreened for the selection of the 562 or 561
children included in the study.
 
It is observed that the proportion of children who had ever had a diagnosis of asthma is practically
same as that of children whose asthma was well controlled (respectively 55.9% and 55.5%). Could
this not mean that the majority of children with poor asthma control was mostly made up of children
whose asthma was only diagnosed due to or during the study?
 
The authors state that they “looked at the correlation between asthma control in the last four weeks
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The authors state that they “looked at the correlation between asthma control in the last four weeks
and type of asthma medication used in the last 12 months to assess the proportion of children
currently with poor asthma control who have received the correct asthma treatment at any point in
the last 12 months”. The reason given for this analysis is not convincing as it is not clear how
receiving correct medication at any point in the last 12 months can explain poor asthma control in
the last four weeks. By the way, nowhere in the text is it mentioned that these children had
persistent asthma to warrant that one should guess that they were prescribed daily maintenance
therapy and that they might have abandoned treatment thereby causing poor control of their
disease. This guess even cannot be true as “clinicians using participants’ detailed asthma
symptoms” prescribed to 279 (50.4%) children step 1 treatment (Salbutamol as needed). By the
way, do we speak of asthma control when patients have a crisis from time to time? I believe
asthma control using the scales the authors used is indicated essentially for evaluating control in
patients with persistent asthma under medication.
 
It would have been interesting to find out if poor asthma control was related to barriers to inhaled
asthma medication use and reported asthma triggers and even treatment offered for these triggers
rather than just give proportions of these factors found in the children. This is important because
apart from medication, preventive measures should be included as a strategy in the management
of these patients.
 
The discussion and abstract have not been reviewed because they might have to be modified in
light of the comments above.
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